hsa-miR-148a

ncRNA information

ncRNA name

hsa-miR-148a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

ALCAM

Cancer information

Cancer name

Breast Cancer

Cancer site

Breast

Treatment information

Treatment type

Chemotherapy

Drug

Tamoxifen

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

We infer that MiR-148a and miR-152 can sensitize TamR MCF-7 cells to tamoxifen at least via downregulating ALCAM.

Tissue resource

breast tumors samples

tamoxifen sensitive human ER+ breast cancer cell lines MCF-7

breast tumors samples

tamoxifen sensitive human ER+ breast cancer cell lines MCF-7

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

the Chi-Mei Medical Center

American Type Culture Collection

the Chi-Mei Medical Center

American Type Culture Collection

Country

China

USA

China

USA

Continent

Asia

Amercia

Asia

Amercia